The Melbourne, Australia project rolls on. The 4th patient (i.e. the last one in the first cohort) has received his/her 30 million stem cells.
The next patient (i.e. the first one in the second cohort of 4 patients) is scheduled to receive 50 million stem cells.
Each of the 4 patients in the third cohort are scheduled to receive 70 million stem cells.
International Stem Cell Corporation Completes First Cohort In Parkinson's Disease Clinical Trial Other OTC:ISCO